Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Synthetic, nonandrogenic DHEA active in animal model of MS

April 28, 1998

New NK1 receptor antagonist ineffective against postherpetic neuralgia

April 27, 1998

Dofetilide exerts atrial positive inotropic effect in AF patients following cardioversion

April 27, 1998

Oral levosimendan effectively substitutes for i.v. inotropic therapy

April 27, 1998

New prokinetic agent emerges from the pipeline at Zeria

April 24, 1998

Immunosuppressive MDR inhibitor isolated from bacterial species

April 24, 1998

Nihon Nohyaku's ACAT inhibitor tested in SHRSP

April 24, 1998

New trypsin inhibitor with potential in treating pancreatitis

April 23, 1998

Kitasato Institute isolates CETP inhibitors from fungus

April 23, 1998

New ACAT inhibitor reported by Kyoto Pharmaceutical

April 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.